9:00 am - 3:00 pm (ET)
Description
Obesity contributes to diseases of the heart-including atherosclerotic cardiovascular disease, arrhythmias, and heart failure with preserved ejection fraction-which often are refractory to treatment. This symposium explores the epidemiology and pathophysiology of obesity-related heart diseases, as well as the role of emerging therapeutics and issues related to prevention, access to treatment, and health equity.
This symposium is hosted by the NIH Obesity Research Task Force and being organized by the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) and the National Heart, Lung, and Blood Institute (NHLBI).
Registration Deadline: September 12, 2024